144 ·Filed Aug 17, 2026

ERAS

Erasca, Inc.
NEUTRAL
Impact 3/10
Horizondays Processed1mo ago SEC0001628280-26-057296
Form 144 — notice of proposed sale of securities
Actionable Insight • Neutral

This is a small, recurring sale by a foundation affiliate with no insider (CEO/CFO) involvement. The pattern of identical monthly blocks suggests a 10b5-1 plan or systematic donation-related disposition. No material bearish signal — monitor for any acceleration in selling frequency or a change to open-market sales by officers.

DirectionNeutral
Confidencehigh
Horizondays
Latest settled — T+20d
ERAS ▼ -11.60% at T+20d
NEUTRAL call ✗ call lost -11.60% · α vs SPY -10.07% · entry $18.28 → $16.16
Next anchor: T+60d in 6w
Latest observation: T+32 -41.26% FF3 residual α
Entry anchored
Aug 17, 02:13 PM ET
via 1-min bar
T+1d
-0.98%
call -0.98% · α -0.31%
$18.10
settled 6w ago
T+5d
-3.72%
call -3.72% · α -2.53%
$17.60
settled 6w ago
T+20d
-11.60%
call -11.60% · α -10.07%
$16.16
settled 17d ago
T+60d
—
call — · α —
—
in 6w

Price Chart

Loading chart...

Executive Summary

Erasca Foundation, a major affiliate holder, filed a Form 144 on August 17, 2026, signaling intent to sell 8,333 shares of Erasca, Inc. common stock, with an approximate market value of $152,419 based on the filing date price. The shares were acquired via donation on July 20, 2021, and the seller has also sold identical amounts in June and July 2026, suggesting a pre-arranged or periodic selling plan. The sale is small relative to the $6.4B market cap and the foundation's likely large position, making it a routine liquidity event with minimal directional signal for the stock.

Key Facts

  • Erasca Foundation filed Form 144 to sell 8,333 shares of ERAS common stock.
  • Estimated sale value ~$152,419 based on filing date.
  • Shares were originally acquired via donation on July 20, 2021.
  • The foundation sold identical 8,333-share blocks on June 15, 2026 and July 21, 2026, indicating a recurring pattern.

Financial Impact

Proposed sale of 8,333 shares worth ~$152,419 — less than 0.01% of Erasca's $6.4B market cap.

dilution

Risk Factors

  • If the foundation accelerates selling beyond the current 8,333-share monthly pattern, it could signal reduced conviction from a major holder.
  • No risk of material dilution given the tiny size relative to market cap.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
82% bullish (17 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001628280-26-057296
Document: 0001628280-26-057296-index.html0001628280-26-057296
Document: 0001628280-26-057296.txt0001628280-26-057296
21 reports for ERAS
Performance horizon
89% Hit rate 8 of 9 directional calls best @ T+60▲ +95.35%Apr 27, 2026
Filters
Rows
Reports for ERAS — sortable, filterable
TypeNow
Aug 24, 2026
5w ago
8-K
BULLISH ★ 5/10
$17.60 $15.55▼ −11.65%▼ −12.96%$14.94 (−15.09%)
Aug 17, 2026
6w ago
144
NEUTRAL ★ 3/10
$18.28 $16.16▼ −11.60%▼ −10.07%$14.94 (−18.24%)
Aug 13, 2026
7w ago
Institutional Cluster
BULLISH ★ 6/10
$17.86 $15.88▼ −11.09%▼ −9.34%$14.94 (−16.32%)
Aug 12, 2026
7w ago
3
NEUTRAL ★ 2/10
$17.86 $15.88▼ −11.09%▼ −9.34%$14.94 (−16.32%)
Aug 11, 2026
7w ago
Press Release
NEUTRAL ★ 5/10
$18.58 $16.03▼ −13.72%▼ −11.83%$14.94 (−19.56%)
Jul 22, 2026
10w ago
Press Release
BEARISH ★ 6/10
$19.51 $18.07▲ +7.38%▲ +10.28%$14.94 (+23.40%)
Jul 14, 2026
11w ago
8-K
MIXED ★ 6/10
$21.26 $18.58▼ −12.61%▼ −14.95%$14.94 (−29.70%)
Jul 14, 2026
11w ago
424B5
MIXED ★ 6/10
$21.26 $18.58▼ −12.61%▼ −14.95%$14.94 (−29.70%)
Jul 14, 2026
11w ago
Press Release
BEARISH ★ 7/10
$19.50 $18.31▲ +6.10%▲ +8.59%$14.94 (+23.36%)
Jul 13, 2026
11w ago
Press Release
BULLISH ★ 7/10
$19.50 $18.31▼ −6.10%▼ −8.59%$14.94 (−23.36%)
Showing 10 of 21

US Market Status

Market Open — Closes in 3h 58m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access